From off-period dystonia to peak-dose chorea
Identifieur interne : 002517 ( Istex/Curation ); précédent : 002516; suivant : 002518From off-period dystonia to peak-dose chorea
Auteurs : Paul Krack [Allemagne] ; Pierre Pollak ; Patricia Limousin [Royaume-Uni] ; Abdelhamid Benazzouz ; Gu Nther Deuschl [Allemagne] ; Alim-Louis BenabidSource :
- Brain [ 0006-8950 ] ; 1999-06.
English descriptors
- KwdEn :
Abstract
The effect of chronic bilateral high-frequency stimulation of the subthalamic nucleus (STN) on levodopa-induced dyskinaesias was investigated in eight patients with fluctuating Parkinson's disease complicated by functionally disabling off-period dystonia. All of the patients also had severe diphasic and peak-dose chorea, so that it was possible to study the effect of high-frequency stimulation on the different types of levodopa-induced dyskinaesias. Off-period fixed dystonia was reduced by 90% and off-period pain by 66%. After acute levodopa challenge, high-frequency stimulation of the STN reduced diphasic mobile dystonia by 50% and peak-dose choreic dyskinaesias by 30%. The effect of bilateral high-frequency stimulation of the STN on the Unified Parkinson's Disease Rating Scale motor score had the same magnitude as the preoperative effect of levodopa. This allowed the levodopa dose to be reduced by 47%. The combination of reduced medication and continuous high-frequency stimulation of the STN reduced the duration of on-period diphasic and peak-dose dyskinaesias by 52% and the intensity by 68%. Acute high-frequency stimulation of the STN mimics an acute levodopa challenge, concerning both parkinsonism and dyskinaesias, and suppresses off-period dystonia. Increasing the voltage can induce repetitive dystonic dyskinaesias, mimicking diphasic levodopa-induced dyskinaesias. A further increase in voltage leads to a shift from a diphasic-pattern dystonia to a peak-dose pattern choreodystonia. Chronic high-frequency stimulation of the STN also mimics the benefit of levodopa on parkinsonism and improves all kinds of levodopa-induced dyskinaesias to varying degrees. Off-period dystonia, associated with neuronal hyperactivity in the STN is directly affected by stimulation and disappears immediately. The effect of chronic high-frequency stimulation of the STN on diphasic and peak-dose dyskinaesias is more complex and is related directly to the functional inhibition of the STN and indirectly to the replacement of the pulsatile dopaminergic stimulation by continuous functional inhibition of the STN. Chronic high-frequency stimulation of the STN allows a very gradual increase in stimulation parameters with increasing beneficial effect on parkinsonism while reducing the threshold for the elicitation of stimulation-induced dyskinaesias. In parallel with improvement of parkinsonism, the levodopa dose can be gradually decreased. As diphasic dystonic dyskinaesias are improved to a greater degree than peak-dose dyskinaesias, both direct and indirect mechanisms may be involved. Peak-dose choreatic dyskinaesias, associated with little evidence of parkinsonism and thus with low neuronal activity in the STN, are improved, mostly indirectly. Fixed off-period dystonia, mobile diphasic dystonia and peak-dose choreodystonia seem to represent a continuous clinical spectrum reflecting a continuous spectrum of underlying activity patterns of STN neurons.
Url:
DOI: 10.1093/brain/122.6.1133
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002519
Links to Exploration step
ISTEX:8F037AEB01C2F6CB70E4BD26EC8AF299425834CCCuration
No country items
Pierre Pollak<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France,</mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France,</mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France,</mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">From off-period dystonia to peak-dose chorea</title>
<author><name sortKey="Krack, Paul" sort="Krack, Paul" uniqKey="Krack P" first="Paul" last="Krack">Paul Krack</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France,</mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Neurology Department, Christian Albrecht Universität, Kiel, Germany and</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Neurology Department, Christian Albrecht Universität, Kiel</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France,</mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Limousin, Patricia" sort="Limousin, Patricia" uniqKey="Limousin P" first="Patricia" last="Limousin">Patricia Limousin</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France,</mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>MRC Human Movement and Balance Unit, Queen Square, London, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>MRC Human Movement and Balance Unit, Queen Square, London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Benazzouz, Abdelhamid" sort="Benazzouz, Abdelhamid" uniqKey="Benazzouz A" first="Abdelhamid" last="Benazzouz">Abdelhamid Benazzouz</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France,</mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Deuschl, Gu Nther" sort="Deuschl, Gu Nther" uniqKey="Deuschl G" first="Gu Nther" last="Deuschl">Gu Nther Deuschl</name>
<affiliation wicri:level="1"><mods:affiliation>Neurology Department, Christian Albrecht Universität, Kiel, Germany and</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Neurology Department, Christian Albrecht Universität, Kiel</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Benabid, Alim Louis" sort="Benabid, Alim Louis" uniqKey="Benabid A" first="Alim-Louis" last="Benabid">Alim-Louis Benabid</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France,</mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8F037AEB01C2F6CB70E4BD26EC8AF299425834CC</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1093/brain/122.6.1133</idno>
<idno type="url">https://api.istex.fr/document/8F037AEB01C2F6CB70E4BD26EC8AF299425834CC/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002519</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002519</idno>
<idno type="wicri:Area/Istex/Curation">002517</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">From off-period dystonia to peak-dose chorea</title>
<author><name sortKey="Krack, Paul" sort="Krack, Paul" uniqKey="Krack P" first="Paul" last="Krack">Paul Krack</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France,</mods:affiliation>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Neurology Department, Christian Albrecht Universität, Kiel, Germany and</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Neurology Department, Christian Albrecht Universität, Kiel</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France,</mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Limousin, Patricia" sort="Limousin, Patricia" uniqKey="Limousin P" first="Patricia" last="Limousin">Patricia Limousin</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France,</mods:affiliation>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>MRC Human Movement and Balance Unit, Queen Square, London, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>MRC Human Movement and Balance Unit, Queen Square, London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Benazzouz, Abdelhamid" sort="Benazzouz, Abdelhamid" uniqKey="Benazzouz A" first="Abdelhamid" last="Benazzouz">Abdelhamid Benazzouz</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France,</mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Deuschl, Gu Nther" sort="Deuschl, Gu Nther" uniqKey="Deuschl G" first="Gu Nther" last="Deuschl">Gu Nther Deuschl</name>
<affiliation wicri:level="1"><mods:affiliation>Neurology Department, Christian Albrecht Universität, Kiel, Germany and</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Neurology Department, Christian Albrecht Universität, Kiel</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Benabid, Alim Louis" sort="Benabid, Alim Louis" uniqKey="Benabid A" first="Alim-Louis" last="Benabid">Alim-Louis Benabid</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Joseph Fourier University, Grenoble, France,</mods:affiliation>
<wicri:noCountry code="subField"></wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Brain</title>
<title level="j" type="abbrev">Brain</title>
<idno type="ISSN">0006-8950</idno>
<idno type="eISSN">1460-2156</idno>
<imprint><publisher>Oxford University Press</publisher>
<date type="published" when="1999-06">1999-06</date>
<biblScope unit="volume">122</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1133">1133</biblScope>
<biblScope unit="page" to="1146">1146</biblScope>
</imprint>
<idno type="ISSN">0006-8950</idno>
</series>
<idno type="istex">8F037AEB01C2F6CB70E4BD26EC8AF299425834CC</idno>
<idno type="DOI">10.1093/brain/122.6.1133</idno>
<idno type="local">1221133</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0006-8950</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>GPi = globus pallidus internus</term>
<term>HFS = high-frequency stimulation</term>
<term>LID = levodopa-induced dyskinaesias</term>
<term>Parkinson's disease</term>
<term>STN = subthalamic nucleus</term>
<term>UPDRS = Unified Parkinson's Disease Rating Scale</term>
<term>deep brain stimulation</term>
<term>dystonia</term>
<term>levodopa-induced dyskinaesias</term>
<term>subthalamic nucleus</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The effect of chronic bilateral high-frequency stimulation of the subthalamic nucleus (STN) on levodopa-induced dyskinaesias was investigated in eight patients with fluctuating Parkinson's disease complicated by functionally disabling off-period dystonia. All of the patients also had severe diphasic and peak-dose chorea, so that it was possible to study the effect of high-frequency stimulation on the different types of levodopa-induced dyskinaesias. Off-period fixed dystonia was reduced by 90% and off-period pain by 66%. After acute levodopa challenge, high-frequency stimulation of the STN reduced diphasic mobile dystonia by 50% and peak-dose choreic dyskinaesias by 30%. The effect of bilateral high-frequency stimulation of the STN on the Unified Parkinson's Disease Rating Scale motor score had the same magnitude as the preoperative effect of levodopa. This allowed the levodopa dose to be reduced by 47%. The combination of reduced medication and continuous high-frequency stimulation of the STN reduced the duration of on-period diphasic and peak-dose dyskinaesias by 52% and the intensity by 68%. Acute high-frequency stimulation of the STN mimics an acute levodopa challenge, concerning both parkinsonism and dyskinaesias, and suppresses off-period dystonia. Increasing the voltage can induce repetitive dystonic dyskinaesias, mimicking diphasic levodopa-induced dyskinaesias. A further increase in voltage leads to a shift from a diphasic-pattern dystonia to a peak-dose pattern choreodystonia. Chronic high-frequency stimulation of the STN also mimics the benefit of levodopa on parkinsonism and improves all kinds of levodopa-induced dyskinaesias to varying degrees. Off-period dystonia, associated with neuronal hyperactivity in the STN is directly affected by stimulation and disappears immediately. The effect of chronic high-frequency stimulation of the STN on diphasic and peak-dose dyskinaesias is more complex and is related directly to the functional inhibition of the STN and indirectly to the replacement of the pulsatile dopaminergic stimulation by continuous functional inhibition of the STN. Chronic high-frequency stimulation of the STN allows a very gradual increase in stimulation parameters with increasing beneficial effect on parkinsonism while reducing the threshold for the elicitation of stimulation-induced dyskinaesias. In parallel with improvement of parkinsonism, the levodopa dose can be gradually decreased. As diphasic dystonic dyskinaesias are improved to a greater degree than peak-dose dyskinaesias, both direct and indirect mechanisms may be involved. Peak-dose choreatic dyskinaesias, associated with little evidence of parkinsonism and thus with low neuronal activity in the STN, are improved, mostly indirectly. Fixed off-period dystonia, mobile diphasic dystonia and peak-dose choreodystonia seem to represent a continuous clinical spectrum reflecting a continuous spectrum of underlying activity patterns of STN neurons.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002517 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 002517 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:8F037AEB01C2F6CB70E4BD26EC8AF299425834CC |texte= From off-period dystonia to peak-dose chorea }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |